Jamesk Min News Today : Breaking News, Live Updates & Top Stories | Vimarsana

FDA cleared, evidence-based AI and machine learning-based algorithm detects heart disease-associated ischemia

Data from randomized trial will advance evidence for evaluation and treatment of heart disease by studying actual disease, atherosclerosisDENVER--(BUSINESS WIRE)--Cleerly, the company working to create a new standard of care for the diagnosis of heart disease, today announced the TRANSFORM trial at the American Hear...

An announcement on partners to collaborate in the TRANSFORM trial was made today during the American Heart Association’s (AHA) 2023 Scientific Sessions. Data from the randomized control trial will advance evidence for evaluation and treatment of heart disease by studying actual disease: atherosclerosis.

Cleerly, an artificial intelligence (AI) digital healthcare company, has announced it was named “Best Overall AI Solution” in the sixth annual AI Breakthrough Awards program conducted by AI Breakthrough, a leading market intelligence organization that recognizes the top companies, technologies and products in the global Artificial Intelligence (AI) market.

Postmenopausal women with clogged arteries are at higher risk of heart attacks than men of similar age, according to research presented at EACVI 2023, a scientific congress of the European Society of Cardiology (ESC),1 and published in European Heart Journal - Cardiovascular Imaging.2 The study in nearly 25,000 adults used imaging techniques to examine the arteries and followed patients for heart attacks and death. “The study suggests that a given burden of atherosclerosis is riskier in postmenopausal women than it is in men of that age,” said study author Dr. Sophie van Rosendael of Leide...